View full meeting coverage »

Eyetube Meeting Coverage:

2017 American Society of Retina Specialists Annual Meeting

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD, provides an overview of the phase 2 DEL MAR study with ALG-1001 (Luminate, Allegro) in patients with diabetic macular edema. With stage 1 of the study previously presented, Dr. Boyer details the recent findings of stage 2, which evaluated the safety and efficacy of ALG-1001 with bevacizumab (Avastin, Genentech) pretreatment or ALG-1001 combined with bevacizumab.

luminate


1 / 14 Series: 2017 American Society of Retina Specialists Annual Meeting